Thermal solvent-free synthesis of chromonyl chalcones, pyrazolines and their in vitro antibacterial, antifungal activities

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 27, Issue 1, 2012, Pages 84-91

  Siddiqui, Zeba N ^a   Praveen, Shagufta ^a   Musthafa, T N Mohammed ^a   Ahmad, Anis ^a   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

3 Formylchromone; Antimicrobial activity; Green synthesis

Indexed keywords

1 (4 HYDROXY 6 METHYL 2 OXO 2H PYRAN 3 YL) 3 (4 OXO 4H 1 BENZOPYRAN 3 YL) 2 PROPEN 1 ONE; 1 BENZOTHIAZOLYL 3 (4 HYDROXY 6 METHYL 2 OXO 2H PYRAN 3 YL) 5 (4 OXO 4H 1 BENZOPYRAN 3 YL)PYRAZOLINE; 1 BENZOTHIAZOLYL 5 (4 OXO 4H 1 BENZOPYRAN 3 YL) 3 (2,4,6 PYRIMIDINETRIONE 5 YL)PYRAZOLINE; 1 PHENYL 3 (4 HYDROXY 6 METHYL 2 OXO 2H PYRAN 3 YL) 5 [5 (2 HYDROXYPHENYL) 1 PHENYL PYRAZOL 4 YL]PYRAZOLINE; 1 PHENYL 5 (4 OXO 4H 1 BENZOPYRAN 3 YL) 3 (2,4,6 PYRIMIDINETRION 5 YL)PYRAZOLINE; 3 (4 HYDROXY 6 METHYL 2 OXO 2H PYRAN 3 YL) 5 (4 OXO 4H 1 BENZOPYRAN 3 YL)PYRAZOLINE; 3 (4 OXO 4H 1 BENZOPYRAN 3 YL) 1 (2,4,6 PYRIMIDINETRIONE 5 YL) 2 PROPEN 1 ONE; 3 FORMYLCHROMONE; 5 (4 OXO 4H 1 BENZOPYRAN 3 YL) 3 (2,4,6 PYRIMIDINETRIONE 5 YL)PYRAZOLINE; 5 ACETYL BARBITURIC ACID; CHALCONE DERIVATIVE; CHROMONYL CHALCONE; CIPROFLOXACIN; DEHYDROACETIC ACID; PYRAZOLINE DERIVATIVE; PYRIDINE; SOLVENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DISK DIFFUSION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGAL STRAIN; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; CHALCONES; FUNGI; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; PYRAZOLES; TEMPERATURE;

NEGIBACTERIA; POSIBACTERIA;

EID: 79959904278     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.577035     Document Type: Article

References (31)

1. Oliveira RDR, Maffei CML, Martinez R. Infecção urinária hospitalar por leveduras do gênero Candida. Rev Assoc Med Bras 2001;47:231-235.
2. Diekema DJ, BootsMiller BJ, Vaughn TE, Woolson RF, Yankey JW, Ernst EJ et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004;38:78-85. (Pubitemid 38045876)
3. Georgopapadakou NH. Infectious disease 2001: drug resistance, new drugs. Drug Resist Updat 2002;5:181-191. (Pubitemid 35429448)
4. Zhang W, Berberov EM, Freeling J, He D, Moxley RA, Francis DH. Significance of heat-stable and heat-labile enterotoxins in porcine colibacillosis in an additive model for pathogenicity studies. Infect Immun 2006;74:3107-3114. (Pubitemid 43794499)
5. Shaheen HI, Khalil SB, Rao MR, Abu Elyazeed R, Wierzba TF, Peruski LF Jr et al. Phenotypic profiles of enterotoxigenic Escherichia coli associated with early childhood diarrhea in rural Egypt. J Clin Microbiol 2004;42:5588-5595. (Pubitemid 39664341)
6. Puerto AS, Fernández JG, del Castillo Jde D, Pino MJ, Angulo GP. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Diagn Microbiol Infect Dis 2006;54:135-139. (Pubitemid 43176603)
7. Nolan CM, Chalhub EG, Nash DG, Yamauchi T. Treatment of bacterial meningitis with intravenous amoxicillin. Antimicrob Agents Chemother 1979;16:171-175. (Pubitemid 9237589)
8. Harbottle H, Thakur S, Zhao S, White DG. Genetics of antimicrobial resistance. Anim Biotechnol 2006;17:111-124. (Pubitemid 44837672)
9. Berger S. Incidence of severe side effects during therapy with sulfonylurea and biguanides. Horm Metab Res 1985;17:111-115.
10. Barton D, Ollis WD. (1979). Comprehensive Organic Chemistry,vol 1-6. Oxford: Pergamon.
11. Chemler YY, Leonard E, Koffas MAG. Combinatorial mutasynthesis of flavonoid analogues from acrylic acids in microorganisms. Org Lett 2007;9:1855-1858.
12. Prakash O, Kumar R, Parkash V. Synthesis and antifungal activity of some new 3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl) chromones. Eur J Med Chem 2008;43:435-440. (Pubitemid 351215609)
13. Kuroda M, Uchida S, Watanabe K, Mimaki Y. Chromones from the tubers of Eranthis cilicica and their antioxidant activity. Phytochemistry 2009;70:288-293.
14. Larget R, Lockhart B, Renard P, Largeron M. A convenient extension of the Wessely-Moser rearrangement for the synthesis of substituted alkylaminoflavones as neuroprotective agents in vitro. Bioorg Med Chem Lett 2000;10:835-838. (Pubitemid 30215895)
15. Yu D, Chen CH, Brossi A, Lee KH. Anti-AIDS agents. 60. Substituted 3'R,4′R-di-O-(-)-camphanoyl-2′,2′-dimethyldihydropyrano[2, 3-f[ chromone (DCP) analogues as potent anti-HIV agents. j Med Chem 2004;47:4072-4082. (Pubitemid 38970969)
16. Valenti P, Bisi A, Rampa A, Belluti F, Gobbi S, Zampiron A et al. Synthesis and biological activity of some rigid analogues of flavone-8-acetic acid. Bioorg Med Chem 2000;8:239-246. (Pubitemid 30125673)
17. Horton DA, Bourne GT, Smythe ML. The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 2003;103:893-930.
18. Nowaskowska Z. A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 2007;42:125-137.
19. Acharya BN, Saraswat D, Tiwari M, Shrivastava AK, Ghorpade R, Bapna S et al. Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines. Eur J Med Chem 2010;45:430-438.
20. Tanaka K, Toda F. Solvent-free organic synthesis. Chem Rev 2000;100:1025-1074.
21. Cave GW, Raston CL, Scott JL. Recent advances in solventless organic reactions: towards benign synthesis with remarkable versatility. Chem Commun (Camb) 2001;:2159:2169.
22. Toda F. (2005). Solid State Reaction topics in Current Organic Chemistry. Berlin, Heidelberg, New York: Springer.
23. Wang GW. (2004). Fullerene Mechanochemistry. In: Nalwa HS, ed. Encyclopedia of Nanoscience and Nanotechnology, vol. 3. Stevenson Ranch: American Scientific Publishers, 557.
24. Nohara A, Umetani T, Sanno Y. A facile synthesis of 4-oxo-4H-1- benzopyran-3-carboxaldehydes by vilsmeier reagents. Tetrahedron 1974;30:3353-3561.
25. Singh SP, Sehgal S, Tarar LS, Dhawan SN. Synthesis of 2-[3-methyl or trifluromethyl-5-(2-thienyl)-pyrazol-1-yl]thiazol and benzothiazoles. Indian J Chem 1990;29B:310-314.
26. Jursic BS, Neumann DM. Preparation of 5-formyl and 5-acetyl barbituric acids, including the corresponding Schiff bases and phenyl hydrazones. Tetrahedron Lett 2001;42: 8435-8439. (Pubitemid 33048862)
27. Cruickshank R, Duguid JP, Marmion BP, Swain RHA. (1975). Medicinal Microbiology. 12th edn, vol. II, London: Churchill Livingstone, 196-202.
28. Collins AH. (1976). In: Microbiological Methods, second edn. London: Butterworth.
29. Khan ZK. In vitro and vivo screening techniques for bioactivity screening and evaluation, Proc Int Workshop UNIDO-CDRI 1997:210-211.
30. Varma RS.(1998). Antifungal Agents: Past, Present and Future prospects. Lucknow, India: National Academy of Chemistry & Biology.
31. Wiley RH, Jarboe CH. The Chemistry of Heterocyclic compounds. Interscience, NY: 1967;22:183.